b.well Connected Health and myTomorrows Partner to Revolutionize Clinical Trial Patient Recruitment Through AI-Powered Data Integration
核心洞察
b.well Connected Health (搜索) and myTomorrows (搜索) announced a strategic partnership to transform clinical trial access by combining unified health data with AI-powered trial matching technology.
The collaboration integrates b.well's FHIR-based platform connecting 2.4 million providers and 330+ health plans with myTomorrows (搜索)' clinical trial pre-screening capabilities to reduce patient burden and improve enrollment efficiency.
The partnership enables automated eligibility matching through longitudinal health records, helping pharmaceutical sponsors identify and enroll diverse patient populations faster while reducing traditional recruitment costs.
b.well Connected Health (搜索) and myTomorrows (搜索) have announced a groundbreaking partnership aimed at fundamentally transforming how patients access clinical trials through the integration of unified health data and AI-powered matching technology. The collaboration, announced on May 26, 2026, promises to reduce patient burden while improving enrollment efficiency and connecting eligible patients to relevant clinical trial opportunities earlier in their care journey.
Comprehensive Data Integration Platform
The partnership combines b.well's FHIR-based platform with myTomorrows (搜索)' proven AI-powered clinical trial pre-screening and matching technology. b.well's platform connects health data from nearly 2.4 million providers, more than 330 health plans, multiple state health information exchanges (HIEs), laboratories, pharmacies, and over 350 wearables, health sensors and biomarkers into complete, verified health data.
"I know firsthand that a patient and their family will move mountains to access a clinical trial that could change their outcome. But the system hasn't been set up to allow that," said Kristen Valdes, Founder and CEO of b.well. "Through this collaboration, patients have the power to choose to share their data to find out if there is a trial that could help them. That's not only good for patients, but it is how we diversify trials and get new drugs to market faster."
Automated Eligibility Matching Technology
By leveraging b.well's unified longitudinal health records, the collaboration enables automated eligibility matching through myTomorrows (搜索)' AI-powered platform, eliminating duplicative data gathering and helping patients and care teams discover all relevant options. The integration addresses the persistent need for pharmaceutical companies and trial sites to enroll more diverse patient populations while reducing the time and cost of traditional recruitment methods.
The partnership reflects a broader shift across the healthcare ecosystem toward more transparent, real-time use of health data to accelerate insight, reduce administrative overhead, and support faster, more coordinated decision-making.
Global Impact and Scale
myTomorrows (搜索) brings significant experience to the partnership, having supported more than 17,700 patients and 3,000 physicians across 440+ sites in over 135 countries. The company partners with 10+ of the world's leading pharmaceutical companies and operates through a centralized, multi-stakeholder platform that combines AI-driven insights with human expertise.
"By combining our clinical trial matching expertise with b.well's ability to unify and activate patient health data, we can reach more patients, in more communities, and remove the friction that has historically kept them from accessing emerging treatments," said Michel van Harten, MD, CEO at myTomorrows (搜索). "This partnership opens a new chapter in how the industry approaches clinical trial recruitment at scale."
Technology Infrastructure and Capabilities
b.well Connected Health (搜索) operates as a data-rich digital health platform for AI-powered consumer experiences, personalized care, and better outcomes. The company addresses healthcare's fragmentation problem with a scalable, FHIR-based platform that unifies health data, solutions, and services in one place. Through its proprietary Data Refinery, b.well creates longitudinal health records while cleansing and standardizing fragmented data and delivering proactive insights.
myTomorrows (搜索) functions as a global HealthTech company connecting patients, physicians, trial sites, and BioPharma partners to enable earlier and better access to pre-approval treatments. The company simplifies and brings transparency to the path of discovery and access to treatment, accelerating global patient access while supporting more efficient drug development.
The companies are committed to continued innovation at the intersection of their technology, laying the foundation for a broader vision to bring the best of health data unification and clinical trial matching technology to market.